• 1. N-Hydroxy and N-acyloxy peptides: synthesis and chemical modifications
  James Lawrence,Laure Cointeaux,Pascal Maire,Yannick Vallée,Véronique Blandin Org. Biomol. Chem. 2006 4 3125
• 2. Amino acid fluorides: viable tools for synthesis of peptides, peptidomimetics and enantiopure heterocycles
  Girish Prabhu,N. Narendra,Basavaprabhu,V. Panduranga,Vommina V. Sureshbabu RSC Adv. 2015 5 48331
• 3. Amino acid fluorides: viable tools for synthesis of peptides, peptidomimetics and enantiopure heterocycles
  Girish Prabhu,N. Narendra,Basavaprabhu,V. Panduranga,Vommina V. Sureshbabu RSC Adv. 2015 5 48331
• 4. Total synthesis of antimicrobial and antitumor cyclic depsipeptides
  Wenhua Li,Andreas Schlecker,Dawei Ma Chem. Commun. 2010 46 5403
• 5. Total synthesis of largamide B
  Shiwei Qu,Ying Chen,Xiaoji Wang,Shipeng Chen,Zhengshuang Xu,Tao Ye Chem. Commun. 2015 51 2510

• Solvents and Organic Chemicals Organic Compounds Benzenoids Fluorenes Fluorenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Fluorenes

Recent Advances in Fmoc-l-alanyl Chloride (CAS: 103321-50-2) and Its Applications in Chemical Biology and Pharmaceutical Research

Fmoc-l-alanyl Chloride (CAS: 103321-50-2) is a critical reagent in peptide synthesis, particularly in solid-phase peptide synthesis (SPPS) methodologies. This compound, which features a fluorenylmethyloxycarbonyl (Fmoc) protecting group, is widely utilized for the introduction of alanine residues into peptide chains. Recent studies have highlighted its importance in the development of novel therapeutic peptides, peptidomimetics, and bioconjugates, underscoring its versatility in chemical biology and pharmaceutical research.

One of the most significant advancements in the use of Fmoc-l-alanyl Chloride is its role in the synthesis of peptide-based drugs. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the rapid and efficient coupling of alanine residues, enabling the production of high-purity peptides with minimal side reactions. The study also emphasized the compound's stability under standard SPPS conditions, making it a preferred choice for industrial-scale peptide manufacturing.

In addition to its applications in peptide synthesis, Fmoc-l-alanyl Chloride has been explored for its potential in drug delivery systems. Research published in Bioconjugate Chemistry in early 2024 revealed that Fmoc-l-alanyl Chloride could be used to modify nanoparticles for targeted drug delivery. The study reported that the Fmoc group facilitated the attachment of therapeutic peptides to nanoparticle surfaces, enhancing their bioavailability and specificity. This innovation opens new avenues for the treatment of diseases such as cancer and neurodegenerative disorders.

Another area of interest is the use of Fmoc-l-alanyl Chloride in the development of antimicrobial peptides (AMPs). A recent study in ACS Infectious Diseases highlighted its role in synthesizing AMPs with enhanced stability and activity against multidrug-resistant bacteria. The researchers noted that the Fmoc protection strategy allowed for the precise control of peptide sequence and conformation, which is critical for optimizing antimicrobial efficacy.

Despite its widespread use, challenges remain in the handling and storage of Fmoc-l-alanyl Chloride due to its sensitivity to moisture and heat. Recent advancements in reagent formulation, such as the development of stabilized derivatives, have addressed some of these issues. A 2023 patent application disclosed a novel formulation of Fmoc-l-alanyl Chloride with improved shelf-life and handling properties, which could further streamline its application in large-scale peptide synthesis.

In conclusion, Fmoc-l-alanyl Chloride (CAS: 103321-50-2) continues to be a cornerstone in peptide chemistry, with emerging applications in drug delivery, antimicrobial therapy, and bioconjugation. Ongoing research and technological innovations are expected to expand its utility and address current limitations, solidifying its position as an indispensable tool in chemical biology and pharmaceutical development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)